Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.

[1]  J. Kempen,et al.  Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Barile,et al.  Cytomegalovirus retinitis and FK 506. , 2003, American journal of ophthalmology.

[3]  J. Kempen,et al.  Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. , 2003, Archives of ophthalmology.

[4]  R. R. Ober,et al.  Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? , 2002, Ophthalmology.

[5]  Keiji Fukuda,et al.  Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 , 2002 .

[6]  L. Gopal,et al.  Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients. , 2002, Indian journal of ophthalmology.

[7]  S. Lightman,et al.  Cytomegalovirus Retinitis in Patients With Good Syndrome , 2002 .

[8]  Jennifer I. Lim,et al.  Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. , 2002, American journal of ophthalmology.

[9]  W. Freeman,et al.  IMMUNE RECOVERY VITRITIS AND UVEITIS IN AIDS: Clinical Predictors, Sequelae, and Treatment Outcomes , 2001, Retina.

[10]  J. Kempen,et al.  Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. , 2001, Archives of ophthalmology.

[11]  W. Freeman,et al.  Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. , 2000, American journal of ophthalmology.

[12]  M. Polis,et al.  Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. , 2000, American journal of ophthalmology.

[13]  J. Kempen,et al.  Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. , 2000, American journal of ophthalmology.

[14]  H. W. A. Henderson,et al.  Treatment of immune recovery vitritis with local steroids , 1999, The British journal of ophthalmology.

[15]  W. Freeman,et al.  Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. , 1999, The Journal of infectious diseases.

[16]  D. Jabs,et al.  Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. , 1998, American journal of ophthalmology.

[17]  P. McCluskey,et al.  Ocular complications of heart, lung, and liver transplantation , 1998, The British journal of ophthalmology.

[18]  M. Jacobson,et al.  Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. , 1998, American journal of ophthalmology.

[19]  W. Freeman,et al.  Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. , 1998, Archives of ophthalmology.

[20]  Paul E. Méndez,et al.  Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial , 1997 .

[21]  A. Maguire,et al.  Visual loss in cytomegalovirus retinitis caused by cystoid macular edema in patients without the acquired immune deficiency syndrome. , 1996, Ophthalmology.

[22]  J. Pepose,et al.  Ocular Infection and Immunity , 1996 .

[23]  F. Ferris,et al.  Treatment of Cytomegalovirus Retinitis With Intraocular Sustained-Release Ganciclovir Implant-Reply , 1995 .

[24]  Matthew D. Davis,et al.  Treatment of Cytomegalovirus Retinitis with an Intraocular Sustained-Release Ganciclovir Implant: A Randomized Controlled Trial , 1995 .

[25]  D. Jabs.  Ocular manifestations of HIV infection. , 1995, Transactions of the American Ophthalmological Society.

[26]  F. Ferris,et al.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  W. Green,et al.  The Eye in Bone Marrow Transplantation: VI. Retinal Complications , 1994 .

[28]  W. Freeman,et al.  Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. , 1994, American journal of ophthalmology.

[29]  S. D. Bustros,et al.  Retinal detachments in patients with cytomegalovirus retinitis. , 1991, Archives of ophthalmology.

[30]  H. Kaplan,et al.  A Controlled Retrospective Study of Ganciclovir Treatment for Cytomegalovirus Retinopathy: Use of a Standardized System for the Assessment of Disease Outcome , 1989 .

[31]  D. Jabs,et al.  BW B759U for cytomegalovirus retinitis: intraocular drug penetration. , 1986, Archives of ophthalmology.

[32]  T. Merigan,et al.  Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. , 1980, Annals of internal medicine.

[33]  W. Green,et al.  Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection. , 1977, The American journal of medicine.

[34]  T. H. Weller,et al.  Virologic and clinical observations on cytomegalic inclusion disease. , 1962, The New England journal of medicine.